Delivery Order SPE2DB25D3012-SPE2DB25FWYEV
Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $7,659.43. The contract is a firm fixed price, non-set-aside contract with a period of performance ending on June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,651.46 contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication. The contract is not set aside and has an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,741.64, is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of May 6, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,948.40 firm fixed-price contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, with an ultimate completion date of May 20, 2025 and a ceiling value of $16,542.61. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a ceiling value of $13,649.76 and a performance period through June 4, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $5,457.66. The contract is a firm fixed price, non-set-aside delivery order with a period of performance ending on July 3, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a medication, with a ceiling value of $2,917.72 and a performance period through June 9, 2025. The contract is not set aside and was awarded on June 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, with a ceiling value of $17,115.46 and a performance period through June 11, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ELIQUIS 5 MG TABLET 60S. The contract is a firm fixed-price delivery order with a ceiling value of $8,735.38 and an ultimate completion date of July 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...